Biotin accounts for less than half of all biotin and biotin metabolites in the cerebrospinal fluid of children

American Journal of Clinical Nutrition

Volumn 88, Issue 5, 2008, Pages 1291-1296

  Bogusiewicz, Anna ^a   Stratton, Shawna L ^a   Ellison, Dale A ^a   Mock, Donald M ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTIN; BIOTIN SULFOXIDE; DINORBIOTIN; STREPTAVIDIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING ASSAY; CEREBROSPINAL FLUID; CHILD; GEL ELECTROPHORESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; LUMBAR PUNCTURE; METABOLITE; PROTEIN BINDING; PROTEIN DEGRADATION; WESTERN BLOTTING;

ADOLESCENT; AVIDIN; BINDING, COMPETITIVE; BIOTIN; CEREBROSPINAL FLUID; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; INFANT; MALE;

EID: 55849144710     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.3945/ajcn.2008.26525     Document Type: Article

References (29)

1. Perry TL, Haworth JC, Robinson BH. Brain amino acid abnormalities in pyruvate carboxylase deficiency. J Inherit Metab Dis 1985;8:63-6.
2. Wallace JC, Jitrapakdee S, Chapman-Smith A. Pyruvate carboxylase. Int J Biochem Cell Biol 1998;30:1-5.
3. Said HM. Cellular uptake of biotin: mechanisms and regulation. J Nutr 1999;129(suppl):490S-3S.
4. Wolf B. Disorders of biotin metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular basis of inherited disease. 8th ed. New York, NY: McGraw-Hill, Inc, 2001;3151-77.
5. Anagnostouli M, Livaniou E, Nyalala JO, et al. Cerebrospinal fluid levels of biotin in various neurological disorders. Acta Neurol Scand 1999;99:387-92.
6. Mock DM, Lankford GL, Mock NI. Biotin accounts for only half of the total avidin-binding substances in human serum. J Nutr 1995;125:941-6.
7. Zempleni J, Mock DM. Advanced analysis of biotin metabolites in body fluids allows a more accurate measurement of biotin bioavailability and metabolism in humans. J Nutr 1999;129(suppl):494S-7S.
8. Mock DM. Determinations of biotin in biological fluids. In: McCormick DB, Suttie JW, Wagner C, eds. Methods in enzymology. New York, NY: Academic Press, 1997;265-75.
9. Mock DM, Lankford GL, Cazin J Jr. Biotin and biotin analogs in human urine: Biotin accounts for only half of the total. J Nutr 1993;123:1844-51.
10. Mock DM, Nyalala JO, Raguseo RM. A direct streptavidin-binding assay does not accurately quantitate biotin in human urine. J Nutr 2001;131:2208-14.
11. Mock DM, Malik MI. Distribution of biotin in human plasma: most of the biotin is not bound to protein. Am J Clin Nutr 1992;56:427-32.
12. Lewis B, Rathman S, McMahon RJ. Detection and quantification of biotinylated proteins using the STORM 840 optical scanner. J Nutr Biochem 2003;14:196-202.
13. Apoga D, Ek B, Tunlid A. Analysis of proteins in the extracellular matrix of the plant pathogenic fungus Bipolaris sorokiniana using 2-D gel electrophoresis and MS/MS. FEMS Microbiol Lett 2001;197:145-50.
14. Lombard KA, Mock DM. Biotin nutritional status of vegans, lactovegetarians and non-vegetarians. Am J Clin Nutr 1989;50:486-90.
15. Lo W, Kadlecek T, Packman S. Biotin transport in the rat central nervous system. J Nutr Sci Vitaminol (Tokyo) 1991;37:567-72.
16. Green NM. Avidin. Adv Protein Chem 1975;29:85-133.
17. Zempleni J, Mock DM. Biotin. In: Song WO, Beecher GR, eds. Modern analytical methodologies in fat and water-soluble vitamins. Baltimore, MD: Wiley, 2001;459-66.
18. Mock DM. Biotin analogs account for half of the total avidin-binding substances in human plasma. Clin Res 1989;37:955A (abstr).
19. Spector R, Mock DM. Biotin transport and metabolism in the central nervous system. Neurochem Res 1988;13:213-9.
20. Melville DB. Biotin sulfoxide. J Biol Chem 1954;208:495-501.
21. Wang K-S, Mock NI, Mock DM. Biotin biotransformation to bisnorbiotin is accelerated by several peroxisome proliferators and steroid hormones in rats. J Nutr 1997;127:2212-6.
22. Mock DM, Dyken ME. Biotin catabolism is accelerated in adults receiving long-term therapy with anticonvulsants. Neurology 1997;49:1444-7.
23. Mock DM, Mock NI. Serum concentrations of bisnorbiotin and biotin sulfoxide increase during both acute and chronic biotin supplementation. J Lab Clin Med 1997;129:384-8.
24. Zempleni J, Mock DM. Bioavailability of biotin given orally to humans in pharmacologic doses. Am J Clin Nutr 1999;69:504-8.
25. Wolf B. Biotinidase: its role in biotinidase deficiency and biotin metabolism. J Nutr Biochem 2005;16:441-5.
26. Chauhan J, Dakshinamurti K. Role ofhumanserum biotinidase as biotin-binding protein. Biochem J 1988;256:265-70.
27. Frank O, Luisada-Opper AV, Feingold S, Baker H. Vitamin binding by human and some animal plasma proteins. Nutr Rep Int 1970;1:161-8.
28. Vallotton M, Hess-Sander U, Leuthardt F. Fixation spontanee de la biotine a une proteine dans le serum humain. (Spontaneous fixation of biotin to a protein in human serum.) Hel Chim Acta 1965;48:126-33 (in French).
29. Nagamine T, Takehara K, Fukui T, Mori M. Clinical evaluation of biotin-binding immunoglobulin in patients with Graves' disease. Clin Chim Acta 1994;226:47-54.